“Evaluation of pharmacokinetic and pharmacodynamic interaction between repaglinide and atazanavir in healthy, diabetic and hepatic impaired rats: possible inhibition of CYP3A, OATP, and P-glycoprotein transporters” (2016) ADMET and DMPK, 4(3), pp. 269–279. doi:10.5599/admet.4.3.328.